TheProfitWatch

BCAX - Bicara Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
17.14 1.67 (9.75%) --- --- --- 0.0 (0.0%) 1.44 (8.29%) 0.34 (1.98%) 0.0 (-0.01%)

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.5
Diluted EPS:
-0.5
Basic P/E:
-37.62
Diluted P/E:
-37.62
RSI(14) 1m:
37.59
VWAP:
18.83
RVol:
0.9685

Events

Period Kind Movement Occurred At
Day Price increase day 18.88 +1.74 (+10.16%) Oct 15 15:33
1m Price increase 1m 17.73 +0.26 (+1.47%) Oct 15 09:36

Related News